[
    [
        {
            "time": "2023-03-01",
            "original_text": "涨，停，潮！疫苗连传好消息，下半年医改重点任务已敲定",
            "features": {
                "keywords": [
                    "涨",
                    "停",
                    "潮",
                    "疫苗",
                    "医改",
                    "重点任务"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "涨，停，潮！疫苗连传好消息，下半年医改重点任务已敲定",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-03-02",
            "original_text": "高瓴悬了！凯莱英大改23亿定增案，究竟蕴含怎样的玄机？",
            "features": {
                "keywords": [
                    "高瓴",
                    "凯莱英",
                    "定增",
                    "方案变更"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高瓴悬了！凯莱英大改23亿定增案，究竟蕴含怎样的玄机？",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-03",
            "original_text": "欧菲光定增案“战投”消失 同日宣布发债25亿",
            "features": {
                "keywords": [
                    "欧菲光",
                    "定增",
                    "战投",
                    "发债"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "欧菲光定增案“战投”消失 同日宣布发债25亿",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-03-04",
            "original_text": "500亿医药“白马”定增生变 “包场”的高瓴资本或出局？",
            "features": {
                "keywords": [
                    "医药",
                    "白马",
                    "定增",
                    "高瓴资本",
                    "出局"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "500亿医药“白马”定增生变 “包场”的高瓴资本或出局？",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-05",
            "original_text": "老周侃股：高瓴资本放弃包揽定增释放什么信号",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "定增",
                    "放弃",
                    "信号"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "老周侃股：高瓴资本放弃包揽定增释放什么信号",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-03-06",
            "original_text": "凯莱英修改定增方案 “公募抬轿私募套利”遭市场质疑",
            "features": {
                "keywords": [
                    "凯莱英",
                    "定增",
                    "方案修改",
                    "市场质疑"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "凯莱英修改定增方案 “公募抬轿私募套利”遭市场质疑",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-07",
            "original_text": "从1到35，高瓴资本不再包揽！凯莱英23亿定增方案突变",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "凯莱英",
                    "定增",
                    "方案突变"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "从1到35，高瓴资本不再包揽！凯莱英23亿定增方案突变",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-03-08",
            "original_text": "风向变了？凯莱英23亿定增生变，私募：监管或严格规管战投条件",
            "features": {
                "keywords": [
                    "凯莱英",
                    "定增",
                    "风向变化",
                    "监管",
                    "战投条件"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "风向变了？凯莱英23亿定增生变，私募：监管或严格规管战投条件",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-03-09",
            "original_text": "浙商医药|外包周报：A+H加速布局下医药CXO板块，是否还可以加仓？",
            "features": {
                "keywords": [
                    "浙商医药",
                    "外包",
                    "CXO",
                    "加仓"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "浙商医药|外包周报：A+H加速布局下医药CXO板块，是否还可以加仓？",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2023-03-10",
            "original_text": "投资圈炸锅！高瓴资本扫货A股按下暂停键？",
            "features": {
                "keywords": [
                    "投资圈",
                    "高瓴资本",
                    "扫货",
                    "暂停"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "投资圈炸锅！高瓴资本扫货A股按下暂停键？",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        }
    ]
]